Live tape
Top 8, mentions 7d14,662HTZ4,544 mentions▲ +0.09SPCX2,592 mentions▲ +0.08GOOGL2,138 mentions▲ +0.03NVDA1,205 mentions▲ +0.08NBIS1,158 mentions▲ +0.09SNDK1,117 mentions▲ +0.08MSFT1,066 mentions▲ +0.06SPY842 mentions▲ +0.07

Equity · Healthcare

IQV

IQVIA Holdings Inc. · NYSE

$206.17 −2.29% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 44 sessions
$220 $160 14 May 17 Jul

The line runs $171 on 14 May through $206.17 on 17 July, on a scale from $160 to $220. Days the market did not trade hold the previous close, flat.

The chart above plots the price of IQV over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 44 sessions over that window: $171 on 14 May 2026 through $206.17 on 17 July 2026.

Market cap $34.4B
P/E (TTM) 31.8
52-week range $157 – $244.30
Avg volume 350.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 12, 2026

IQV insider trades

SEC Form 4 · last 90 days · newest reported trade 3 Aug 2026
Open-market buys 0
Open-market sells 5
Net sold $29.19M
Non-trade filings 2
Date Insider Type Shares Value
03 Aug 2026 STAUB W RICHARD See Remarks Sell 5,500 $1.28M
31 Jul 2026 Patel Bhavik See Remarks Sell 1,855 $436K
29 Jul 2026 BOUSBIB ARI See Remarks Sell 106,279 $26.09M
29 Jul 2026 Cherofsky Keriann See Remarks Sell 558 $137K
29 Jul 2026 Sherbet Eric See Remarks Sell 5,000 $1.25M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
29 Jul 2026 BOUSBIB ARI See Remarks Option exercise 156,206 $12.22M
29 Jul 2026 BOUSBIB ARI See Remarks Other 49,927 $12.22M

IQV reported financials

SEC EDGAR XBRL

IQV reported revenue of $16.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $1.4B.

Figure Reported Period
Revenue $16.3B 31 Dec 2025 fiscal year
Net income $1.4B 31 Dec 2025 fiscal year
Diluted EPS $7.84 31 Dec 2025 fiscal year
Total assets $29.7B 31 Mar 2026 at period end
Total equity $6.2B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

IQV earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $1.61
31 Dec 2025 FY 2025 $7.84
30 Sep 2025 Q3 2025 $1.93
30 Jun 2025 Q2 2025 $1.54
31 Mar 2025 Q1 2025 $1.40
31 Dec 2024 FY 2024 $7.49
30 Sep 2024 Q3 2024 $1.55
30 Jun 2024 Q2 2024 $1.97

Reported figures & scheduled dates · SEC EDGAR filings

IQV institutional holders

SEC Form 13F

1 of the 45 institutional funds we track reported a IQV position for the quarter ended 30 Jun 2026 — a combined $969K; the latest of those filings landed 04 Aug 2026.

Fund Action Shares Value
Fisher Asset Management Held (±25%) +5.8% shares 5,016 $969K

Source: SEC EDGAR 13F filings

IQV fails-to-deliver

SEC CNS data

On 10 Jul 2026, 212 shares of IQV failed to deliver (about $44K).

Settlement date Shares failed Notional % of shares out
10 Jul 2026 212 $44K <0.001%

Source: SEC fails-to-deliver (CNS) data